Proteomic Tissue-Based Classifier for Early Prediction of Prostate Cancer Progression

Although ~40% of screen-detected prostate cancers (PCa) are indolent, advanced-stage PCa is a lethal disease with 5-year survival rates around 29%. Identification of biomarkers for early detection of aggressive disease is a key challenge. Starting with 52 candidate biomarkers, selected from existing...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Yuqian, Wang, Yi-Ting, Chen, Yongmei, Wang, Hui, Young, Denise, Shi, Tujin, Song, Yingjie, Schepmoes, Athena A., Kuo, Claire, Fillmore, Thomas L., Qian, Wei-Jun, Smith, Richard D., Srivastava, Sudhir, Kagan, Jacob, Dobi, Albert, Sesterhenn, Isabell A., Rosner, Inger L., Petrovics, Gyorgy, Rodland, Karin D., Srivastava, Shiv, Cullen, Jennifer, Liu, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281161/
https://www.ncbi.nlm.nih.gov/pubmed/32429558
http://dx.doi.org/10.3390/cancers12051268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281161/
https://www.ncbi.nlm.nih.gov/pubmed/32429558
http://dx.doi.org/10.3390/cancers12051268

Ejemplares similares